Rising Pharma Holding, Inc.

FDA Drug Class II Ongoing

Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals

October 7, 2025 Rising Pharma Holding, Inc. 2,064 100-count bottles units

FDA Drug Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99

March 5, 2025 Rising Pharma Holding, Inc. 1223 bottles units

FDA Drug Class II Ongoing

Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ

December 30, 2024 Rising Pharma Holding, Inc. 244,460 bottles units

FDA Drug Class II Ongoing

Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60

December 30, 2024 Rising Pharma Holding, Inc. 73,680 bottles units

FDA Drug Class II Ongoing

Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ

December 30, 2024 Rising Pharma Holding, Inc. 42,527 bottles units

FDA Drug Class II Ongoing

Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceuticals, Inc., East Brunswic

November 19, 2024 Rising Pharma Holding, Inc. 233,003 bottles units

FDA Drug Class II Ongoing

Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharma Hold

November 19, 2024 Rising Pharma Holding, Inc. 122,925 bottles units

FDA Drug Class II Ongoing

Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ NDC 57237-017-60

November 19, 2024 Rising Pharma Holding, Inc. 209,376 bottles units

FDA Drug Class III Ongoing

Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 08816 NDC 64980-124-60

June 24, 2024 Rising Pharma Holding, Inc. 868 tubes units

FDA Drug Class III Ongoing

Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 6498

May 16, 2024 Rising Pharma Holding, Inc. N/A units

FDA Drug Class II Ongoing

buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceut

December 29, 2023 Rising Pharma Holding, Inc. 47,976 bottles units